The US Food and Drug Administration adds environmental impact questions to its consideration of whether oxybenzone and octinoxate will remain available as OTC sunscreen monograph ingredients.
The agency on 12 May published a notice stating that an environmental impact statement (EIS) it is required to prepare for oxybenzone and octinoxate could lead to either or both of the ingredients remaining eligible for inclusion in its OTC sunscreen
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?